These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35844804)

  • 1. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Gut Microbiota and Gastrointestinal Cancer.
    Meng C; Bai C; Brown TD; Hood LE; Tian Q
    Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):33-49. PubMed ID: 29474889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota and gastrointestinal cancer.
    Weng MT; Chiu YT; Wei PY; Chiang CW; Fang HL; Wei SC
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S32-S41. PubMed ID: 30655033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
    Tözün N; Vardareli E
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S191-S196. PubMed ID: 27741173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers.
    Cao C; Yue S; Lu A; Liang C
    Pharmacol Res; 2024 Sep; 207():107321. PubMed ID: 39038631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the microbiome in drug resistance in gastrointestinal cancers.
    Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer.
    Marzhoseyni Z; Shaghaghi Z; Alvandi M; Shirvani M
    Curr Cancer Drug Targets; 2024; 24(6):612-628. PubMed ID: 38213140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma.
    Acharya S; Thirunavukkarasu C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):67. PubMed ID: 38420824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Gut Microbiota in Gastrointestinal Tract Cancers.
    Grochowska M; Perlejewski K; Laskus T; Radkowski M
    Arch Immunol Ther Exp (Warsz); 2022 Feb; 70(1):7. PubMed ID: 35112169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the gut microbiome in gastrointestinal cancers.
    Mishra Y; Ranjan A; Mishra V; Chattaraj A; Aljabali AAA; El-Tanani M; Hromić-Jahjefendić A; Uversky VN; Tambuwala MM
    Cell Signal; 2024 Mar; 115():111013. PubMed ID: 38113978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future-A review.
    Yu J; Li L; Tao X; Chen Y; Dong D
    Crit Rev Oncol Hematol; 2024 Nov; 203():104480. PubMed ID: 39154670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
    Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression.
    Wu H; Ma W; Wang Y; Wang Y; Sun X; Zheng Q
    Biomed Pharmacother; 2024 Apr; 173():116410. PubMed ID: 38460373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?
    Ramai D; Salati M; Pomati G; Amoroso C; Facciorusso A; Botticelli A; Ghidini M
    Curr Opin Pharmacol; 2022 Dec; 67():102315. PubMed ID: 36351361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.
    Gou H; Zeng R; Lau HCH; Yu J
    Pharmacol Res; 2024 Oct; 208():107373. PubMed ID: 39197712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.
    Mima K; Ogino S; Nakagawa S; Sawayama H; Kinoshita K; Krashima R; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Sakamoto Y; Yamashita YI; Yoshida N; Chikamoto A; Ishiko T; Baba H
    Surg Oncol; 2017 Dec; 26(4):368-376. PubMed ID: 29113654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-bacteria microbiome (virus, fungi, and archaea) in gastrointestinal cancer.
    Coker OO
    J Gastroenterol Hepatol; 2022 Feb; 37(2):256-262. PubMed ID: 34825404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.